Weihua Wan
CCCC Highway Consultants (China)(CN)Jiangxi Transportation Research Institute(CN)Guangxi Research Institute of Chemical Industry(CN)
Publications by Year
Research Areas
Advancements in Battery Materials, Advanced Battery Materials and Technologies, Lung Cancer Treatments and Mutations, Cancer therapeutics and mechanisms, HER2/EGFR in Cancer Research
Most-Cited Works
- → Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells(2005)105 cited
- → Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)(2016)89 cited
- → CEP-28122, a Highly Potent and Selective Orally Active Inhibitor of Anaplastic Lymphoma Kinase with Antitumor Activity in Experimental Models of Human Cancers(2011)70 cited
- → Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity(2010)49 cited
- → 2,7-Disubstituted-pyrrolo[2,1-f][1,2,4]triazines: New Variant of an Old Template and Application to the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors with in Vivo Antitumor Activity(2011)42 cited
- → Design, Synthesis, and Anaplastic Lymphoma Kinase (ALK) Inhibitory Activity for a Novel Series of 2,4,8,22-Tetraazatetracyclo[14.3.1.13,7.19,13]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Macrocycles